![Michael Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Weiss
Vorstandsvorsitzender bei
TG THERAPEUTICS, INC.
Vermögen: 377 Mio $ am 31.05.2026
Profil
Herr Michael S. Weiss ist Chairman bei Checkpoint Therapeutics, Inc. und Executive Chairman bei Mustang Bio, Inc. sowie Partner bei Opus Point Partners Management LLC, Partner & Portfolio Manager bei Opus Point Partners LLC und Executive Chairman, President & CEO bei TG Therapeutics, Inc. Er ist Mitglied des Board of Directors von Cyprium Therapeutics, Inc, Fortress Biotech, Inc, Caelum Biosciences, Inc, Cellvation, Inc. und Helocyte, Inc. Zuvor war Herr Weiss als Chairman bei National Holdings Corp. beschäftigt, als Non-Executive Director bei Avenue Therapeutics, Inc. und als Co-Chairman bei CB Pharma Acquisition Corp. sowie als Executive Chairman bei IASO Pharma, Inc, ein Chairman von XTL Biopharmaceuticals Ltd., ein Chairman & Chief Executive Officer von Keryx Biopharmaceuticals, Inc. ein Chairman & Chief Executive Officer von ACCESS Oncology, Inc. ein Chairman von Paligent, Inc. ein Trustee von Cancer Care, Inc. und ein Anwalt von Cravath, Swaine & Moore LLP. Er war außerdem Vorstandsmitglied bei Healthcare Integrated Services, Inc. und Genta, Inc. Er erhielt seinen Bachelor-Abschluss von der State University of New York in Albany und einen Graduiertenabschluss von der Columbia Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 6,39 % | 14.04.2026 | 9 778 086 ( 6,39 % ) | 371 Mio $ | 31.05.2026 |
FORTRESS BIOTECH, INC. 6,85 % | 16.04.2026 | 2 276 562 ( 6,85 % ) | 6 Mio $ | 31.05.2026 |
| 18.11.2025 | 325 ( 0 % ) | 218 $ | 31.05.2026 |
Aktive Positionen von Michael Weiss
| Unternehmen | Position | Beginn |
|---|---|---|
| TG THERAPEUTICS, INC. | Vorstandsvorsitzender | 29.12.2011 |
| FORTRESS BIOTECH, INC. | Direktor/Vorstandsmitglied | 20.12.2013 |
| MUSTANG BIO, INC. | Vorsitzender | 01.05.2015 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Gründer | 01.01.2017 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Direktor/Vorstandsmitglied | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Direktor/Vorstandsmitglied | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Weiss
| Unternehmen | Position | Ende |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.12.2016 |
| AVENUE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 08.02.2019 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Weiss
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
Paligent, Inc.
 Paligent, Inc. Financial ConglomeratesFinance Development stage company | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
National Holdings Corp.
 National Holdings Corp. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides securities brokerage services | Finance |
Healthcare Integrated Services, Inc.
 Healthcare Integrated Services, Inc. Medical/Nursing ServicesHealth Services Operates fixed-site magnetic resonance imaging centers | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Opus Point Partners LLC
 Opus Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
